Aadi Bioscience, Inc.

Historical 13F Holders

Symbol
WHWK
CUSIP
00032Q104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00032Q104 since 12/18/2024, largest first.

Filer % of Class Filed
Avoro Capital Advisors LLC 13D/A
20.0% 5/14/2026
Event 5/12/2026
Suvretta Capital Management, LLC 13G
10.0% 3/11/2025
Event 3/4/2025
ABG Management Ltd. 13G/A
9.4% 8/14/2026
Event 6/30/2026
QVT Financial LP 13G 9.4% 2/14/2025
Event 12/31/2024
Acuta Capital Partners, LLC 13D/A
9.0% 5/18/2026
Event 5/14/2026
OrbiMed Advisors LLC 13G/A
7.3% 8/14/2026
Event 6/30/2026
Coastlands Capital LP 13G
6.0% 8/25/2025
Event 8/19/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
BML Investment Partners, L.P. 13D/A
4.98% 3/5/2025
Event 3/5/2025
Neil Desai 13D/A 4.9% 3/6/2025
Event 3/4/2025
EcoR1 Capital, LLC 13G/A
1.4% 2/14/2025
Event 12/31/2024
Point72 Asset Management, L.P. 13G/A
0% 5/15/2025
Event 3/31/2025
Satter Muneer A 13G/A 0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 374 $1.41 k
2026 Q2 78 43.2 M $198 M
2026 Q1 64 35.2 M $123 M
2025 Q4 48 33.0 M $79.2 M
2025 Q3 42 28.8 M $54.3 M
2025 Q2 40 29.4 M $54.6 M
2025 Q1 53 31.8 M $56.4 M
2024 Q4 57 16.1 M $50.8 M
2024 Q3 55 12.0 M $24.7 M
2024 Q2 70 11.5 M $16.8 M
2024 Q1 66 14.1 M $33.1 M
2023 Q4 70 13.3 M $26.9 M
2023 Q3 77 14.7 M $75.3 M
2023 Q2 70 14.3 M $101 M
2023 Q1 73 14.3 M $107 M
2022 Q4 81 15.6 M $196 M
2022 Q3 71 15.1 M $212 M
2022 Q2 71 13.2 M $159 M
2022 Q1 58 12.8 M $220 M
2021 Q4 47 12.2 M $295 M
2021 Q3 33 11.1 M $324 M